OxySure Systems, Inc. (OTCQB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently reported revenues that increased a whopping 762% to $240,000 during the first quarter of 2013 after expanding its product offering to include six brands of AEDs and signing several new distribution deals.
The company’s recent launch of a new cabinet to house both AEDs and OxySure units in one cabinet will further strengthen the technology’s place in emergency preparedness. Meanwhile, the new cabinet will also help enhance the attractiveness and appeal of the OxySure unit by making it easier for institutional customers to house the product in a convenient way that saves space, time and money.
Investors in AED-focused equities like Medtronic Inc. (NYSE: MDT) and Koninklijke Philips NV (NYSE: PHG) may want to take a closer look at OxySure Systems given its improving fundamentals. Building on its previous momentum from Q1, and with an expanding product line, OxySure is well-positioned to escalate its targeting of the 3+ million AED companion market.
Please Click Here to Read the Full OxySure Systems, Inc. Press Release
http://secfilings.com/News.aspx?title=oxysure_systems_(oxys)_launches_new_cabinet_for_aed/oxysure_oxygen_device&naid=469
About Emerging Growth LLC
EGC is a marketing and consulting firm that specializes in creating ongoing communications strategies for public and private companies.
Disclosure:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx